Avoiding deceptive imprinting of the immune response to HIV-1 infection in vaccine development

被引:14
作者
Muller, S [1 ]
机构
[1] Immpheron Inc, Lexington, KY 40509 USA
关键词
HIV-1; infection; pediatric AIDS; AIDS vaccine; lymphocyte; clonal restriction; original antigenic sin; anti-idiotypic antibodies;
D O I
10.1080/08830180490432802
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphocyte clonal restriction is caused by priming the immune system with an antigen and has been referred to infectious disease study as "original antigenic sin" (OAS), described first for influenza by Francis [1]. OAS is a dominant feature of a normal immune response. Benefits of OAS come from the initial contact with the pathogen, which induces immunological memory. Memory is achieved by priming B and T cells of an immunologically naive host, and confers protection against infection with the antigen-related pathogen. Thus, a restricted antibody response to viral or parasite antigens is not per se pathogenic. However, the interplay between a "locked-in" immune response and the high genetic variation of the pathogenic agent can result in a deception of the immune system. In the following, clonal restriction of the immune response to HIV is described by giving examples of restricted anti-HIV antibody formation in maternally infected children. Clonal restriction results in host resistance of infected individuals to emerging HIV variants and quasispecies. The problems of classical approaches of vaccine design in AIDS and the lack of protection in vaccinated patients is reviewed.
引用
收藏
页码:423 / 436
页数:14
相关论文
共 53 条
[1]   Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus [J].
Agadjanyan, M ;
Luo, P ;
Westerink, MAJ ;
Carey, LA ;
Hutchins, W ;
Steplewski, Z ;
Weiner, DB ;
KieberEmmons, T .
NATURE BIOTECHNOLOGY, 1997, 15 (06) :547-551
[2]  
AMADORI A, 1989, J IMMUNOL, V143, P2146
[3]  
[Anonymous], 1994, MMWR Recomm Rep, V43, P1
[4]  
ATTANASIO R, 1991, J IMMUNOL, V146, P507
[5]   ANTIIDIOTYPIC ANTIBODIES OF A PREDEFINED SPECIFICITY GENERATED AGAINST CDR3VH SYNTHETIC PEPTIDES DEFINE A PRIVATE ANTI-CD4 IDIOTYPE [J].
ATTANASIO, R ;
KENNEDY, RC ;
ALLAN, JS ;
MAINO, VC ;
BUCK, D ;
KANDA, P .
MOLECULAR IMMUNOLOGY, 1990, 27 (06) :513-522
[6]   Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [J].
Barouch, DH ;
Santra, S ;
Schmitz, JE ;
Kuroda, MJ ;
Fu, TM ;
Wagner, W ;
Bilska, M ;
Craiu, A ;
Zheng, XX ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Nickerson, CE ;
Trigona, WL ;
Punt, K ;
Freed, DC ;
Guan, LM ;
Dubey, S ;
Casimiro, D ;
Simon, A ;
Davies, ME ;
Chastain, M ;
Strom, TB ;
Gelman, RS ;
Montefiori, DC ;
Lewis, MG ;
Emini, EA ;
Shiver, JW ;
Letvin, NL .
SCIENCE, 2000, 290 (5491) :486-492
[7]  
BERBERIAN L, 1991, BLOOD, V78, P175
[8]  
BERBERIAN L, 1994, J ACQ IMMUN DEF SYND, V7, P641
[9]   IMMUNOGLOBULIN-V(H)3 GENE-PRODUCTS - NATURAL LIGANDS FOR HIV GP120 [J].
BERBERIAN, L ;
GOODGLICK, L ;
KIPPS, TJ ;
BRAUN, J .
SCIENCE, 1993, 261 (5128) :1588-1591
[10]   CLEARANCE OF HIV-INFECTION IN A PERINATALLY INFECTED INFANT [J].
BRYSON, YJ ;
PANG, S ;
WEI, LS ;
DICKOVER, R ;
DIAGNE, A ;
CHEN, ISY .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (13) :833-838